Form 4: Outset Medical CFO Sells Shares to Cover Tax Obligations
SEC Form 4
Outset Medical's Chief Financial Officer, Nabeel Ahmed, sold 4,221 shares of common stock to cover tax obligations related to vesting of restricted stock units.
Summary
- Nabeel Ahmed, the Chief Financial Officer of Outset Medical, Inc., sold 4,221 shares of common stock on November 15, 2024.
- The sale was executed at a price of $0.8 per share.
- This transaction was not a discretionary trade but rather a 'sell to cover' transaction to meet tax withholding obligations.
- The shares were sold to cover taxes associated with the vesting of 7,761 shares of common stock underlying restricted stock units (RSUs).
- These RSUs were granted to Mr. Ahmed on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023.
- Following the transaction, Mr. Ahmed beneficially owns 310,767 shares of Outset Medical common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.
Comparison to Industry Standards
- Similar 'sell to cover' transactions are common across the industry for executives receiving stock-based compensation.
- The sale of shares to cover tax obligations is a standard practice and does not indicate any negative sentiment towards the company's prospects.
- Many companies, such as Medtronic and Boston Scientific, have executives who regularly engage in similar transactions.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
- The sale does not indicate any change in the CFO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/08/2021 | Grant date of some of the RSUs that triggered the tax obligation. |
| 08/05/2021 | Grant date of some of the RSUs that triggered the tax obligation. |
| 01/26/2022 | Grant date of some of the RSUs that triggered the tax obligation. |
| 01/06/2023 | Grant date of some of the RSUs that triggered the tax obligation. |
| 11/15/2024 | Date of the stock sale transaction. |
| 11/18/2024 | Date the form was signed. |
Keywords
Outset Medical, Nabeel Ahmed, CFO, stock sale, tax obligations, restricted stock units, RSUs, sell to cover, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.